Biotech and Money Logo 2018 - Logo.png         Medtech and Money World Congress 2018.png

 

Bringing deals to life.

5-6th February 2018, etc. venues, 200 Aldersgate, St. Pauls, London EC1A 4HD

DOWNLOAD THE BROCHURE
REGISTER NOW

2018 Event Partners

ABOUT THE 2018 WORLD CONGRESS

The 4th annual Biotech and Money / Medtech and Money World Congress is a high-calibre, senior Executive, two-day conference and partnering event providing the education, strategies, solutions and contacts that life science companies need to enable more effective  investment, business planning and partnering within their businesses.

With our relentless focus on quality peer-2-peer discussion, high-level networking and partnering, unique formats and a vetted, high-calibre audience, we bring together the people that matter to the future of healthcare and life science funding, finance, investment and deal making.

The 2017 conference officially attracted the largest gathering of active Life Science investors in Europe, making it the go to event for Executives looking to engage in investment and partnering discussions. It's the must attend 2018 event for corporates, investors and pharma.

DOWNLOAD THE BROCHURE

 

9 CORE ELEMENTS TO 1 INCREDIBLE 2-DAY CONGRESS

 

        VIEW THE 2018 BROCHURE FOR

  • - The 2018 attending companies 
  • - What's new for February 2018
  • - What makes the 2018 event unique
  • - The 2018 agenda and speakers
  • - Who attended in 2017
  • - Plus much more...
DOWNLOAD THE BROCHURE
Biotech and Money Brochure

      SNAPSHOT OF THE 2018 KEYNOTES AND SPEAKER FACULTY

 

Tony Hickson
Managing Director, Imperial Innovations

Tim Luker

Tim Luker
Director, Eli Lilly & Co

Daniel O'Mahony

Daniel O'Mahony
Partner, Seroba Life Sciences

Christoph Ruedig

Christoph Ruedig
Partner, Albion Capital

Claudio Rumazza

Claudio Rumazza
Partner, Innogest

Alain Huriez

Alain Huriez
Managing Partner, Advent France Biotechnology

Edoardo Negroni

Edoardo Negroni
Managing Partner, AurorA-TT

Gerry Maguire

Gerry Maguire
General Partner, Atlantic Bridge

Giovanni Mariggi

Giovanni Mariggi
Principal, Medicxi

Edward Van Wezel

Edward Van Wezel
Managing Partner, BioGeneration Ventures

James Shaw

James Shaw
Co-Founder, JAG Shaw Baker

Jean-Philippe Combal

Jean-Philippe Combal
CEO, Vivet Therapeutics

Janke Dittmer

Janke Dittmer
Partner, GildeHealthcare

Jennifer Laird

Jennifer Laird
Senior Director, Eli Lilly & Co.

John Zai

John Zai
CEO, Cocoon Networks

Joachim Rautter

Joachim Rautter
Managing Director, Peppermint

Kate Bingham

Kate Bingham
Managing Partner, SV Health Investors

Johnston Erwin

Johnston Erwin
Vice President, Eli Lilly & Co.

Jonathan Goldstein

Jonathan Goldstein
Director, Boston Scientific Ventures

Martin Frost

Martin Frost
CEO, Cambridge Medical Robotics

Pascale Auge

Pascale Auge
CEO, Inserm Transfert

Onno Van De Stolpe

Onno Van De Stolpe
CEO, Galapagos

Piyush Unalkat

Piyush Unalkat
Head of Technology Transfer, EIF

Thom Rasche

Thom Rasche
Partner, Earlybird Venture Capital

Tommi Lehtonen

Tommi Lehtonen
CEO, Blueprint Genetics

Sander Slootweg

Sander Slootweg
Managing Director, Forbion Capital Partners

Paul Saunders

Paul Saunders
Head of Innovation Investments, Ireland's Strategic Investment Fund

Paul Ashley

Paul Ashley
Head of Technology Transfer, Oxford University Innovation

Chandra Leo

Chandra Leo
Investment Advisor, HBM Partners

Iain Thomas

Iain Thomas
Head of Life Sciences, Cambridge Enterprise

Rob De Ree

Rob De Ree
Chairman, Mellon Medical

Steve Atkinson

Steve Atkinson
CEO, Atlantic Therapeutics

TARA RAVEENDRAN

Tara Raveendran
Head of Life Sciences Research, Shore Capital

Gita Dittmar

Gita Dittmar
Head of Corporate Development, Ethris

ANGUS GRANT SVP Business Development CELGENE

Angus Grant
SVP Business Development, Celgene

MICHAEL STEIN CEO OXSTEM

Michael Stein
CEO, Oxstem

PEKKA SIMULA CEO HERANTIS PHARMA

Pekka Simula
CEO, Herantis Pharma

CHRISTOPHER CLEARY VP Corporate Development MEDTRONIC

Christopher Clearly
VP Corporate Development, Medtronic

TAUHID ALI

Tauhid Ali
VP & Head of TAK-celerator, Takeda

RAÚL INSA CEO SOM BIOTECH

Raul Insa
CEO, Som Biotech

MARTIN OSTERMAIER CEO INTERAX

Martin Ostermaier
CEO, Interax

THOMAS LIENARD

Thomas Lienard
CEO, Bone Therapeutics

RANDOLPH HUBBELL CEO CARMELL THERAPEUTICS

Randolph Hubbell
CEO, Carmell Therapeutics

FRED JACOBS CEO TYG - ONCOLOGY

Fred Jacobs
CEO, TYG - Oncology

CARLOS DE SOUSA CEO IMMUNICIUM

Carlos De Sousa
CEO, Immunicium

PHIL L'HUILLIER Head European Innovation Hub MSD

Phil L'huillier
Head European Innovation Hub, MSD

PAVITHRA SUNDARESAN Senior Director New Ventures and Transaction Lead J & J INNOVATION

Pavithra Sundaresan
Senior Director New Ventures and Transaction Lead, J & J Innovation

CHRISTIAN SCHETTER CEO RIGONTEC

Christian Schetter
CEO, Rigontec

RODGER NOVAK CEO CRISPR THERAPEUTICS

Rodger Novak
CEO, Crispr Therapeutics

MIGUEL COSTA CEO AGLARIS CELL

Miguel Costa
CEO, Aglaris Cell

THERESA DEISHER CEO AVM BIOTECHNOLOGY

Theresa Deisher
CEO, AVM Biotechnology

TUSHAR SINGHVI VP Corporate Development and Investments CRESCENT ENTERPRISES

Tushar Singvhi
VP Corporate Development and Investments, Crescent Enterprises

VANESSA MALIER Managing Partner KURMA PARTNERS

Vanessa Malier
Managing Partner, Kurma Partners

CLIVE COOKSON Science Editor FINANCIAL TIMES

Clive Cookson
Science Editor, Financial Times

NIALL MARTIN CEO ARTIOS PHARMA

Niall Martin
CEO, Artios Pharma

ERICA WHITTAKER HEAD OF UCB VENTURES UCB PHARMA

Erica Whittaker
Head of UCB ventures, UCB Pharma

ELAINE WARBURTON CEO QUANTUMDX

Elaine Warburton
CEO, QuantuMDx

TIM HAINES Managing Partner ABINGWORTH

Tim Haines
Managing Partner, Abingworth

ASAF HOMOSSANY Managing Director, EMEA NASDAQ

Asaf Homossany
Managing Director EMEA, NASDAQ

ADAM KOSTYÁL SVP and Head of European Listings NASDAQ

Adam Kostyal
SVP and Head of European Listings, NASDAQ

NIELS RIEDEMANN CEO INFLARX

Niels Riedemann
CEO, Inflarx

XAVIER BERTRAND Global GM Symetis & VP International SH Valves BOSTON SCIENTIFIC

Xavier Bertrand
Global GM Symetis & VP International SH Valves, Boston Scientific

BEVERLEY CARR Business Development, Immunoinflammation Therapy Area GSK

Beverley Carr
Business Development, Immunoinflammation Therapy Area, GSK

Sourabh Pagaria

Sourabh Pagaria
Senior Vice President and General Manager, Siemens Healthineers

ANDREW SHAILER-SMITH CEO ASTRAVEUS

Andrew Shailer- Smith
CEO, Astraveus

DAVID HIPKISS CEO ENESI PHARMA

David Hipkiss
CEO, Enesi Pharma

SIMON HUBBERT CEO LIG TECHNOLOGIES

Simon Hubbert
CEO, LIG Technologies

TIM WILSON CEO IGEM THERAPEUTICS

Tim Wilson
CEO, IGEM Therapeutics

PAUL KO FERRIGNO CEO METALINEAR

Paul Ko Ferringno
CEO, Metalinear

SHAUN GRADY VP GLOBAL BUSINESS DEVELOPMENT ASTRAZENECA

Shaun Grady
VP Global Business Development, Astrazeneca

TIMM JESSEN CEO TOPAS THERAPEUTICS

Timm Jessen
CEO, Topas Therapeutics

JEAN CHRISTOPHE RENONDIN Senior Investment Manager Healthcare OMAN INVESTMENT FUND

Jean Christophe Renondin
Senior Investment Manager Healthcare, Oman Investment Fund

RAINER LICHTENBERGER CEO ATRIVA THERAPEUTICS

Rainer Lichtenberger
CEO, Atriva Therapeutics

ASSAF BARNEA CEO SANARA VENTURES

Assaf Barnea
CEO, Sanara Ventures

CELINE-LEA HALIOUA-HAUBOLD CEO OISIN BIOTECHNOLOGIES

Celine- Lea Halioua- Haubold
CEO, Oisin Biotechnologies

FLORENCE SEJOURNE CEO DA VOLTERRA

Florence Sejourne
CEO, Da Volterra

PATRICK VAN BENEDEN Partner GIMV

Patrick Van Beneden
Partner, GIMV

JAMES GREENE CEO MEDLUMICS

James Greene
CEO, Medlumics

PAWEL PRZEWIEZLIKOWSKI CEO SELVITA

Pawel Przewielikowski
CEO, Selvita

ISABEL VAN DE KEERE CEO IMMERSIVE REHAB

Isabel Van De Keere
CEO, Immersive Rehab

DAVID BERRY General Partner FLAGSHIP PIONEERING

David Berry
General Partner, Flagship Pioneering

ELISA PETRIS PARTNER SYNCONA PARTNERS

Elisa Petris
Partner, Syncona Partners

JOE ANDERSON CEO ARIX BIOSCIENCES

Joe Anderson
CEO, Arix Biosciences

PHILIPPE LOPES-FERNANDES

Philippe Lopes- Fernandes
Head of Global Business Development & Alliance Management, EMD Serono

NAVEED SIDDIQI

Naveed Siddiqi
Partner, Edmond De Rothschild Investment Partners

SARAH HOWELL CEO ARECOR

Sarah Howell
CEO, Arecor

NEIL CLARK CEO DESTINY PHARMA

Neil Clark
CEO, Destiny Pharma

RICHARD DAVIES CEO BONE SUPPORT

Richard Davies
CEO, Bone Support

MARC LEMONNIER CEO ANTABIO

Marc Lemonnier
CEO, Antabio

PIERRE CHAUVINEAU VP BOSTON SCIENTIFIC

Pierre Chauvineau
VP, Boston Scientific

ADAM HILL CMO MCLAREN APPLIED TECHNOLOGIES

Adam Hill
CMO, McLaren Applied Technologies

ISOBEL FINNIE Partner HASELTINE LAKE

Isobel Finnie
Partner, Haseltine Lake

CHRISTOPH KAUSCH Founding Partner and CEO MTIP MEDTECH INNOVATION PARTNERS

Christoph Kausch
Founding Partner & CEO, MTIP Medtech Innovation Partners

ALEXIA PEROUSE CEO IBIONEXT GROWTH FUND

Alexia Perouse
CEO, Ibionext Growth Fund

MARTIN PFISTER Senior Investment Manager HIGH-TECH GRUNDERFONDS

Martin Pfister
Senior Investment Manager, High-Tech Grunderfonds

JASPER BOS Jasper Bos VICE PRESIDENT, HEAD OF THE HEALTHCARE FUND

Jasper Bos
VP & Head of Healthcare, Merck Ventures

DARRIN DISLEY CEO HORIZON DISCOVERY GROUP

Darrin Disley
CEO, Horizon Discovery Group

EDWIN MOSES CEO ABLYNX

Edwin Moses
CEO, Ablynx

TIMOTHY HERPIN VP and Head of Transactions and BD ASTRAZENECA

Timothy Herpin
VP & Head of Transactions and BD, Astrazeneca

HANS LOIBNER CEO APEIRON BIOLOGICS

Hans Loibner
CEO, Apeiron Biologics

BILLY BOYLE CEO OWLSTONE MEDICAL

Billy Boyle
CEO, Owlstone Medical

HUBERT BIRNER Managing Partner TVM CAPITAL LIFE SCIENCE

Hubert Birner
Managing Partner, TVM Capital Life Science

IAIN DUKES Venture Partner ORBIMED

Iain Dukes
Venture Partner, OrbiMed

VIKTOR DRVOTA CEO KAROLINSKA DEVELOPMENT

Viktor Drvota
CEO, Karolinska Development

DEBORAH HARLAND Partner SR-ONE

Deborah Harland
Partner, SR- One

DIRK KERSTEN Managing Director INKEF CAPITAL

Dirk Kersten
Managing Director, Inkef Capital

NISSIM DARVISH Senior Managing Director ORBIMED

Nissim Darvish
Senior Managing Director, OrbiMed

Speaker Name

Søren Møller
Managing Partner, Novo Seeds

FRANK HENSEL Senior Investment Manager HIGH-TECH GRUNDERFONDS

Frank Hensel
Senior Investment Manager, High-Tech Grunderfonds

2018 EVENT VENUE

Address: etc.venues, 200 Aldersgate,

St. Pauls, London, EC1A 4HD

Email: theteam@etcvenues.co.uk

Phone: +44 (0) 20 7105 6090

CONTACT US

Address : Suite 125, The Business Design Centre, 52 Upper St, London N1 0QH, UK

Email: info@biotechandmoney.com

Phone: +44 (0) 203 637 5908